These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31884599)

  • 21. Hammerhead ribozyme targeting connective tissue growth factor mRNA blocks transforming growth factor-beta mediated cell proliferation.
    Blalock TD; Yuan R; Lewin AS; Schultz GS
    Exp Eye Res; 2004 Jun; 78(6):1127-36. PubMed ID: 15109919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of hammerhead ribozymes and their applications in vivo: rapid identification of functional genes in the post-genome era by novel hybrid ribozyme libraries.
    Takagi Y; Suyama E; Kawasaki H; Miyagishi M; Taira K
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1145-9. PubMed ID: 12440992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular selection of trans-cleaving hammerhead ribozymes.
    Huang X; Zhao Y; Pu Q; Liu G; Peng Y; Wang F; Chen G; Sun M; Du F; Dong J; Cui X; Tang Z; Mo X
    Nucleic Acids Res; 2019 Mar; 47(5):2514-2522. PubMed ID: 30649474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo.
    Taylor NR; Kaplan BE; Swiderski P; Li H; Rossi JJ
    Nucleic Acids Res; 1992 Sep; 20(17):4559-65. PubMed ID: 1408757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribozyme- and deoxyribozyme-strategies for medical applications.
    Schubert S; Kurreck J
    Curr Drug Targets; 2004 Nov; 5(8):667-81. PubMed ID: 15578948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects.
    Grassi G; Forlino A; Marini JC
    Nucleic Acids Res; 1997 Sep; 25(17):3451-8. PubMed ID: 9254703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy.
    LaVail MM; Yasumura D; Matthes MT; Drenser KA; Flannery JG; Lewin AS; Hauswirth WW
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11488-93. PubMed ID: 11005848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural similarities between hammerhead ribozymes and the spliceosomal RNAs could be responsible for lack of ribozyme cleavage in yeast.
    Castanotto D; Li H; Chow W; Rossi JJ; Deshler JO
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):1-13. PubMed ID: 9512091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ribozymes: from mechanistic studies to applications in vivo.
    Ohkawa J; Koguma T; Kohda T; Taira K
    J Biochem; 1995 Aug; 118(2):251-8. PubMed ID: 8543555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of hammerhead ribozyme kinetic constants at high molar ratio ribozyme-substrate.
    Grassi G; Grassi M; Kuhn A; Kandolf R
    J Math Biol; 2002 Sep; 45(3):261-77. PubMed ID: 12373347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivery of a hammerhead ribozyme specifically down-regulates the production of fibrillin-1 by cultured dermal fibroblasts.
    Kilpatrick MW; Phylactou LA; Godfrey M; Wu CH; Wu GY; Tsipouras P
    Hum Mol Genet; 1996 Dec; 5(12):1939-44. PubMed ID: 8968747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
    Kisich KO; Freedland SJ; Erickson KL
    Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of mutant p53 in hepatocellular carcinoma cells by hammerhead ribozyme].
    Kong XJ; Lin JS; Song YH; Shen X; Jin YX
    Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):722-4. PubMed ID: 14697131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hammerhead ribozymes as therapeutic agents for bladder cancer.
    Irie A; Kashani-Sabet M; Scanlon KJ; Uchida T; Baba S
    Mol Urol; 2000; 4(2):61-6. PubMed ID: 12006244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of hammerhead ribozymes cleaving mdr-1 mRNA.
    Palfner K; Kneba M; Hiddemann W; Bertram J
    Biol Chem Hoppe Seyler; 1995 May; 376(5):289-95. PubMed ID: 7544982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pH-dependent conformational change, rather than the chemical step, appears to be rate-limiting in the hammerhead ribozyme cleavage reaction.
    Murray JB; Dunham CM; Scott WG
    J Mol Biol; 2002 Jan; 315(2):121-30. PubMed ID: 11779233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA.
    Hovig E; Maelandsmo G; Mellingsaeter T; Fodstad O; Mielewczyk SS; Wolfe J; Goodchild J
    Antisense Nucleic Acid Drug Dev; 2001 Apr; 11(2):67-75. PubMed ID: 11334142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid, cell-based toxicity screen of potentially therapeutic post-transcriptional gene silencing agents.
    Kolniak TA; Sullivan JM
    Exp Eye Res; 2011 May; 92(5):328-37. PubMed ID: 21256844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hammerhead ribozyme: structure, catalysis, and gene regulation.
    Scott WG; Horan LH; Martick M
    Prog Mol Biol Transl Sci; 2013; 120():1-23. PubMed ID: 24156940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.